Добірка наукової літератури з теми "Pregnancy and safety"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Pregnancy and safety".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Pregnancy and safety"
Yalcinkaya, E., M. Celik, B. Bugan, and UC Yuksel. "Safety concerns in pregnancy." Clinics 68, no. 4 (April 25, 2013): 577. http://dx.doi.org/10.6061/clinics/2013(04)23.
Повний текст джерелаVarse, Ramona Georgiana, Nicolae Gica, Radu Botezatu, Gheorghe Peltecu, and Anca Maria Panaitescu. "Hydroxychloroquine - safety in pregnancy." Romanian Journal of Rheumatology 31, no. 1 (March 31, 2022): 5–9. http://dx.doi.org/10.37897/rjr.2022.1.1.
Повний текст джерелаNewsome, Melba. "Drug safety in pregnancy." New Scientist 250, no. 3338 (June 2021): 20–21. http://dx.doi.org/10.1016/s0262-4079(21)00992-1.
Повний текст джерелаLevi-Schaffer, Francesca, and David Mankuta. "Omalizumab safety in pregnancy." Journal of Allergy and Clinical Immunology 145, no. 2 (February 2020): 481–83. http://dx.doi.org/10.1016/j.jaci.2019.11.018.
Повний текст джерелаScialli, Anthony R. "Drug safety in pregnancy." Reproductive Toxicology 5, no. 5 (January 1991): 459. http://dx.doi.org/10.1016/0890-6238(91)90013-6.
Повний текст джерелаLam, Y. W. Francis. "Alprazolam safety in pregnancy." Brown University Psychopharmacology Update 34, no. 2 (December 27, 2022): 2–3. http://dx.doi.org/10.1002/pu.30971.
Повний текст джерелаNaleway, Allison L., Bradley Crane, Stephanie A. Irving, Don Bachman, Kimberly K. Vesco, Matthew F. Daley, Darios Getahun, et al. "Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination." Therapeutic Advances in Drug Safety 12 (January 2021): 204209862110212. http://dx.doi.org/10.1177/20420986211021233.
Повний текст джерела&NA;. "Safety of antithrombotics in pregnancy." Reactions Weekly &NA;, no. 427 (November 1992): 2. http://dx.doi.org/10.2165/00128415-199204270-00001.
Повний текст джерелаClayden, Polly. "Safety of Antiretrovirals in Pregnancy." Southern African Journal of HIV Medicine 10, no. 1 (March 23, 2009): 15. http://dx.doi.org/10.4102/sajhivmed.v10i1.311.
Повний текст джерелаDonner, Barbara, Viswanathan Niranjan, and Gerhard Hoffmann. "Safety of Oseltamivir in Pregnancy." Drug Safety 33, no. 8 (August 2010): 631–42. http://dx.doi.org/10.2165/11536370-000000000-00000.
Повний текст джерелаДисертації з теми "Pregnancy and safety"
Meijer, Willemijn Marieke. "Drug safety in pregnancy studying and communicating teratogenic risks /." [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2006. http://irs.ub.rug.nl/ppn/297900455.
Повний текст джерелаChi, Ching-Chi. "Evidence-based assessment of the safety of topical corticosteroids in pregnancy." Thesis, University of Oxford, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.504309.
Повний текст джерелаEsch, Jennifer, and Guadalupe Sandoval. "Pharmacy Student Knowledge of Teratogens to Avoid in Pregnancy." The University of Arizona, 2010. http://hdl.handle.net/10150/623792.
Повний текст джерелаOBJECTIVES: The purpose of the study was to determine the knowledge of third year pharmacy students about the safety of certain medications during pregnancy and to assess their awareness of an important resource available on medication safety. METHODS: The study used an analytical cross-‐sectional design. A pre-‐test was administered to determine baseline knowledge. Dee Quinn provided a presentation on teratogens. The same test was then administered as a post-‐test to assess the amount of knowledge gained from the presentation. The pre and post-‐tests were matched for data analysis. A mean and standard deviation were developed for pre and post-‐test data and the results were compared to each other using a t-‐test for dependent groups. RESULTS: Students showed a significant increase in knowledge after the presentation (p<0.0001). 78% of students had improved scores after the presentation. 100% of students felt that pharmacists could help make a difference in preventing malformations due to teratogen exposure. There was no significant difference between men and women or students with children and without children. Work experience did not affect knowledge scores. 64% of students felt more comfortable counseling pregnant patients after the presentation. Awareness of the Teratology Information Service improved after the presentation. CONCLUSIONS: After the presentation, students rated themselves as more comfortable speaking with pregnant patients and showed improved knowledge of teratogens. Gender, being a parent and work experience had no relevance on knowledge scores. The investigators recommend that this presentation be given to all students at the College of Pharmacy to improve knowledge in this area.
Leke, Aminkeng Z. "Maternal use and safety of anti-infectives in pregnancy, with special reference to Cameroon." Thesis, Ulster University, 2017. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.716360.
Повний текст джерелаPerera, Dhammika. "A Comparison of the Safety and Efficacy of Three Medical Abortion Protocols." ScholarWorks, 2019. https://scholarworks.waldenu.edu/dissertations/6649.
Повний текст джерелаLind, Jennifer N. "Maternal Medication Use and Risk of Hypospadias- An Exposure Spectrum Approach." Digital Archive @ GSU, 2012. http://digitalarchive.gsu.edu/iph_theses/207.
Повний текст джерелаCharlton, Rachel. "The general practice research database as an alternative to registries for studying drug safety in pregnancy : anticonvulsants as a case study." Thesis, University of Bath, 2012. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557803.
Повний текст джерелаViljoen, Estelle. "A systematic review of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting." Thesis, Stellenbosch : Stellenbosch University, 2012. http://hdl.handle.net/10019.1/20265.
Повний текст джерелаENGLISH ABSTRACT: Background: Nausea and vomiting during pregnancy (NVP) is a common medical condition. Due to possible harmful side-effects that conventional medicine may pose to the fetus, many mothers choose not to use it, and are left helpless against NVP. There is a need for alternative treatment to relieve NVP symptoms. Objectives: This systematic review (SR) investigated current evidence regarding ginger for the treatment of NVP. The primary objective was to assess the effectiveness of ginger in treating NVP. The secondary objective was to assess the safety of ginger during pregnancy, by identifying adverse events or side-effects. Search strategy: Electronic search of bibliographic databases (1966-February 2011). Selection criteria: Randomized controlled trials (RCTs) of the efficacy of ginger by any route, as treatment for NVP in pregnant women regardless of their age or stage of pregnancy. Data collection and analysis: The principal investigator and independent reviewer individually identified relevant studies, extracted data and assessed trial quality. Data analysis was performed using the RevMan5 software. Differences at the level of p<0.05 were considered to be statistically significant. Results: Eleven RCTs involving 1176 pregnant women were included. The quality of evidence was low, hence the high risk of bias and imprecision of results. Ginger significantly improved the symptoms of nausea when compared to placebo, when comparing the results of this SR to past SRs, and taking into account a meta-analysis performed on two relatively large included studies (mean difference (MD) 1.20, 95% confidence interval (CI) 0.56-1.84, p=0.0002, I2=0%). However, another meta-analysis on two smaller studies indicated no significant improvement in nausea. Ginger did not significantly improve nausea when compared to vitamin B6 (MD 0.34, 95% CI -1.52-2.20, p=0.7, I2=91%). Similarly, ginger did not significantly reduce the number of vomiting episodes during NVP, when compared to placebo, although there was a trend towards improvement (MD 0.72, 95% CI -0.03-1.46, p=0.06, I2=71%). Subgroup analyses performed seemed to favor the lower daily dosage of <1500mg ginger to possibly be more effective for the relief of nausea. Ginger did not pose a significant risk for spontaneous abortion when compared to placebo (RR 3.14, 95% CI 0.65-15.11, p=0.15; I2=0%), or to vitamin B6 (RR 0.49, 95% CI 0.17-1.42, p=0.19, I2=40%). Similarly, ginger did not pose a significant risk for the side effects of heartburn or drowsiness when compared to placebo or vitamin B6. When compared to dimenhydrinate, ginger posed a smaller risk for drowsiness (RR 0.08, 95% CI 0.03-0.18) and no increased risk for heartburn. Conclusions: This review suggests potential benefits of ginger in reducing nausea symptoms in pregnancy (bearing in mind the limited number of studies, variable outcome reporting and quality of evidence). Ginger did not have a significant impact on vomiting episodes, nor pose a risk for side effects or adverse events during pregnancy. Based on evidence from this SR, ginger could be considered a harmless and possibly effective alternative option for women suffering from the symptoms of NVP. Large RCTs are necessary to confirm the possible benefit of ginger as treatment for NVP.
AFRIKAANSE OPSOMMING: Agtergrond: Naarheid en vomering tydens swangerskap (NVS) is ‘n algemene mediese toestand. As gevolg van moontlike skadelike newe-effekte wat konvensionele medikasie kan veroorsaak vir die fetus, vermy baie moeders dit en word hulpeloos gelaat teen NVS. Dus is daar behoefte aan alternatiewe behandeling vir NVS. Doelwitte: Hierdie sistematiese literatuuroorsig (SO) het huidige literatuur ondersoek wat verband hou met gemmer vir behandeling van NVS. Die primêre doelwit was om effektiwiteit van gemmer as behandeling vir NVS te assesseer. Die sekondêre doelwit was om veiligheid van gemmer tydens swangerskap te assesseer, deur ongunstige gebeure en newe-effekte te identifiseer. Soektogstrategie: Elektroniese soektog van bibliografiese databasisse (1966-Februarie 2011). Seleksiekriteria: Verewekansigde gekontrolleerde proewe (RCTs) van gemmer deur enige roete as behandeling van NVS, in swanger vroue ongeag ouderdom of stadium van swangerskap. Dataversameling en –analise: Die hoof navorser en ‘n onafhanklike hersiener het individueel relevante studies geidentifiseer, data ekstraksie onderneem en studie-kwaliteit geassesseer. Data-analise is uitgevoer deur die RevMan5 sagteware te gebruik. Verskille by die vlak van p<0.05 was beskou as statisties betekenisvol. Hoof resultate: Elf RCTs waarby 1176 swanger vroue betrokke was, is ingesluit. Die studie-kwaliteit was swak, dus die hoë risiko vir sydigheid en onakkuraatheid van resultate. Gemmer het beduidend die simptome van naarheid verbeter in vergelyking met plasebo, wanneer die resultate van hierdie SO met vorige SO’s vergelyk word, en die meta-analise in ag geneem word wat op twee relatiewe groot ingeslote studies uitgevoer is (gemiddelde verskil (MD) 1.20, 95% vertrouens interval (VI) 0.56-1.84, p=0.0002,I2=0%). Kontrasterend, het ‘n ander meta-analise van twee kleiner studies geen beduidende verbetering in naarheid aangedui nie. Gemmer het nie beduidend naarheid verbeter wanneer dit met vitamien B6 vergelyk word nie (MD 0.34, 95% VI -1.52-2.20, p=0.7, I2=91%). Soortgelyk, het gemmer nie die aantal vomerings-episodes verminder, in verglyking met plasebo nie, maar daar was wel ‘n neiging na verbetering (MD 0.72, 95% VI -0.03-1.46, p=0.06, I2=71%). Die subgroup-analise blyk ten gunste te wees van die laer daaglikse dosis van <1500mg gemmer om meer effektief te wees vir die behandeling van naarheid. Gemmer het nie ‘n beduidende risiko ingehou vir spontane aborsie, wanneer dit vergelyk word met plasebo (relatiewe risiko (RR) 3.14, 95% VI 0.65-15.11,p=0.15;I2=0%), of vitamien B6 nie (RR 0.49, 95% VI 0.17-1.42,p=0.19;I2=40%). Soortgelyk, het gemmer nie ‘n beduidende risiko ingehou vir newe-effekte van sooibrand of duiseligheid, wanneer dit vergelyk word met plasebo of vitamien B6 nie. Wanneer dit vergelyk word met dimenhidrinaat, het gemmer ‘n kleiner risiko ingehou vir duiseligheid (RR 0.08, 95% VI 0.03-0.18) en geen verhoogde risiko vir sooibrand nie. Gevolgtrekkings: Hierdie SO dui ‘n potensiële voordeel van gemmer aan in vermindering van naarheid tydens swangerskap (inagnemend van die klein hoeveelheid studies, wisselende uitkomste-rapportering en studie-kwaliteit). Gemmer het nie ‘n beduidnede impak gehad op vomerings-episodes nie, en ook nie ‘n risiko ingehou vir newe-efekte of ongunstige gebeure tydens swangerskap nie. Volgens bewyse uit hierdie SO, kan gemmer beskou word as ‘n skadelose en moontlike effektiewe alternatiewe opsie vir vroue wat lei aan NVP. Grootskaalse RCTs is nodig om die moontlike voordeel van gemmer as behandeling vir NVS te bevestig.
Weekes, Alix M. "Systems for the automotive industry for improved safety of pregnant occupants." Thesis, Loughborough University, 2010. https://dspace.lboro.ac.uk/2134/6374.
Повний текст джерелаMoustafa, Moustafa. "Fetus safety in motor vehicle accidents." Thesis, Loughborough University, 2014. https://dspace.lboro.ac.uk/2134/16308.
Повний текст джерелаКниги з теми "Pregnancy and safety"
Aegerter, Mary. Food safety during your pregnancy. [Pullman, Wash.]: Cooperative Extension, Washington State University, 2000.
Знайти повний текст джерелаMedication safety in pregnancy and breastfeeding. New York, NY: McGraw-Hill, Health Professions Division, 2007.
Знайти повний текст джерелаKenen, Regina H. Pregnancy at work: Health and safety for the working woman. London: Pluto in association with Maternity Alliance, 1998.
Знайти повний текст джерелаKenen, Regina. Pregnancy at work: Health and safety for the working woman. London: Pluto Press, in association with Maternity Alliance, 1998.
Знайти повний текст джерелаJan, Gerris, Olivennes F, and Sutter Petra de, eds. Assisted reproductive technologies: Quality and safety. Boca Raton: Parthenon Pub. Group, 2003.
Знайти повний текст джерелаAbrams, Richard S. Will it hurt the baby?: The safe use of medications during pregnancy and breastfeeding. Reading, Mass: Addison-Wesley Pub. Co, 1990.
Знайти повний текст джерелаAbrams, Richard S. Will it hurt the baby?: The safe use of medications during pregnancy and breastfeeding. Reading, Mass: Addison-Wesley Pub. Co., 1990.
Знайти повний текст джерелаRayburn, William F., and Paul A. Gluck. Patient safety in obstetrics and gynecology: Improving outcomes, reducing risks. Philadelphia: Saunders, 2008.
Знайти повний текст джерелаN, Hudson Christopher, Sharp F, and Royal College of Obstetricians and Gynaecologists (Great Britain). Study Group, eds. AIDS and obstetrics and gynaecology. London: Springer-Verlag, 1988.
Знайти повний текст джерела1946-, Mossman Kenneth L., and Mills William A. 1929-, eds. The Biological basis of radiation protection practice. Baltimore: Williams & Wilkins, 1992.
Знайти повний текст джерелаЧастини книг з теми "Pregnancy and safety"
Chambers, Christina D., and Elizabeth B. Andrews. "Drug Safety in Pregnancy." In Mann's Pharmacovigilance, 611–24. Oxford, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118820186.ch40.
Повний текст джерелаPettker, Christian M. "Patient Safety." In Queenan's Management of High-Risk Pregnancy, 439–44. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781119963783.ch53.
Повний текст джерелаDudley, Matthew Z., Daniel A. Salmon, Neal A. Halsey, Walter A. Orenstein, Rupali J. Limaye, Sean T. O’Leary, and Saad B. Omer. "Vaccines and Pregnancy." In The Clinician’s Vaccine Safety Resource Guide, 29–30. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-94694-8_4.
Повний текст джерелаAdeli, Bahar, Erkanda Ikonomi, and Asyia Ahmad. "Safety of Procedures During Pregnancy." In Gastrointestinal and Liver Disorders in Women’s Health, 347–69. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-25626-5_23.
Повний текст джерелаDjokanovic, Nada, and Gideon Koren. "Safety of Medications During Pregnancy and Breastfeeding." In Neonatology, 358–63. Milano: Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-1405-3_51.
Повний текст джерелаChambers, Christina. "Safety of Asthma and Allergy Medications During Pregnancy." In Asthma, Allergic and Immunologic Diseases During Pregnancy, 15–27. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-030-03395-8_2.
Повний текст джерелаJan, Matevž, David Žižek, Vesna Fabjan Vodušek, and Bor Antolič. "Safety of Zero-Fluoroscopic Catheter Ablation During Pregnancy." In Cardiac Electrophysiology Without Fluoroscopy, 199–205. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-16992-3_16.
Повний текст джерелаChatterjee, Manas, Manish Khandare, and Vibhu Chatterjee. "Topical Corticosteroid During Pregnancy: Indications, Safety and Precautions." In A Treatise on Topical Corticosteroids in Dermatology, 81–86. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4609-4_6.
Повний текст джерелаSpigset, Olav, and Hedvig Nordeng. "Safety of Psychotropic Drugs in Pregnancy and Breastfeeding." In Pharmacovigilance in Psychiatry, 299–319. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-24741-0_15.
Повний текст джерелаStephens, Sally. "Safety and Pharmacovigilance of Herbal Medicines in Pregnancy." In Pharmacovigilance for Herbal and Traditional Medicines, 77–91. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-07275-8_6.
Повний текст джерелаТези доповідей конференцій з теми "Pregnancy and safety"
Marques, Grazielle de Oliveira, Guilherme Rodrigues Fontes Moura, Gabriela Brill Ney, and Pablo Henrique da Costa Silva. "Neuromyelitis optica (NMO): treatment during pregnancy." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.284.
Повний текст джерелаTent, Michiel. "New safety data of anti-CD20 mAbs around pregnancy." In ECTRIMS Congress 2022, edited by Hans-Peter Hartung. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/c67dae84.
Повний текст джерелаAcar, B. Serpil, M. Moustafa, Volkan Esat, and Memis Acar. "Pregnant Occupant Model Including a Fetus for Vehicle Safety Investigations." In ASME 2014 12th Biennial Conference on Engineering Systems Design and Analysis. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/esda2014-20513.
Повний текст джерелаPinto, Isabella, Rayone Costa, Mariana Freitas, Antony Stevens, and Maria de Fátima Souza. "PW 1793 Rape and pregnancy of adolescents in brazil: characteristics and implications for gestational health, delivery and birth." In Safety 2018 abstracts. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/injuryprevention-2018-safety.305.
Повний текст джерелаFu, Luoyu, Peiqi Yi, Zikun Gao, and Yan Gan. "Design and Research of Flexible Wearable Medical Testing Equipment for Pregnant Women." In 13th International Conference on Applied Human Factors and Ergonomics (AHFE 2022). AHFE International, 2022. http://dx.doi.org/10.54941/ahfe1001478.
Повний текст джерелаNamazy, Jennifer, Michael D. Cabana, Angela Scheuerle, John M. Thorp, Jr., Hubert Chen, Mary K. Miller, Gillis Carrigan, Yan Wang, and Elizabeth B. Andrews. "The Xolair Pregnancy Registry (EXPECT): An Observational Study Of The Safety Of Omalizumab During Pregnancy In Women With Asthma." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4221.
Повний текст джерелаGershman, Ari, Jennifer A. Namazy, Mary K. Miller, Vivian Wang, and Elizabeth Andrews. "The Xolair Pregnancy Registry (Expect): Design Of An Observational Study Of Safety Of (Omalizumab) During Pregnancy In Women With Asthma." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4494.
Повний текст джерелаAcar, B. Serpil, Alix M. Weekes, and David van Lopik. "Anthropometric Modelling of the Pregnant Occupant." In ASME 7th Biennial Conference on Engineering Systems Design and Analysis. ASMEDC, 2004. http://dx.doi.org/10.1115/esda2004-58151.
Повний текст джерелаResende, L., and M. Teixiera. "202 Safety and efficacy of neoadjuvant chemotherapy for cervix adenocarcinoma during pregnancy: case report." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.202.
Повний текст джерелаMeroni, M., E. Generali, G. M. Guidelli, M. Parodi, M. Cutolo, and C. Selmi. "THU0319 Overall safety of 7-week secukinumab exposure during pregnancy in women with psoriatic arthritis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.4760.
Повний текст джерелаЗвіти організацій з теми "Pregnancy and safety"
Zhang, Aolin, Hongliang Xie, Xuan Mou, Ling Ying Tang, Wing Fong Lee, Lang Zhang, Caihong Wang, et al. Efficacy and safety of acupuncture as a treatment for low back and pelvic girdle pain during pregnancy. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0104.
Повний текст джерелаLi, Yanhui, and Cuiju Hua. Comparison of the Efficacy and Subsequent Pregnancy Outcomes of High-intensity Focused Ultrasound and Uterine Artery Embolization in the Chinese Population: Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2022. http://dx.doi.org/10.37766/inplasy2022.10.0053.
Повний текст джерелаGidengil, Courtney, Matthew Bidwell Goetz, Margaret Maglione, Sydne J. Newberry, Peggy Chen, Kelsey O’Hollaren, Nabeel Qureshi, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality (AHRQ), May 2021. http://dx.doi.org/10.23970/ahrqepccer244.
Повний текст джерелаXu, Lingxia, Donmei Yan, Bin Li, Liping Tang, Peng Sun, and Fei Wang. Efficacy and safety of Yunkang oral liquil combined with conventional therapy for threatened miscarriage of first-trimester pregnancy A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2021. http://dx.doi.org/10.37766/inplasy2021.4.0105.
Повний текст джерелаRamaRao, Saumya, and Sarah Raifman. The pregnancy cycle approach to safe motherhood. Population Council, 2010. http://dx.doi.org/10.31899/rh1.1001.
Повний текст джерелаSinha, Dipa. Empowering communities to make pregnancy safer: An intervention in rural Andhra Pradesh. Population Council, 2008. http://dx.doi.org/10.31899/rh5.1026.
Повний текст джерелаSanthya, K. G. Making pregnancy safe for women in Rajasthan: Targeting the most vulnerable. Population Council, 2009. http://dx.doi.org/10.31899/pgy15.1004.
Повний текст джерелаCantor, Amy, Heidi D. Nelson, Miranda Pappas, Chandler Atchison, Brigit Hatch, Nathalie Huguet, Brittny Flynn, and Marian McDonagh. Effectiveness of Telehealth for Women’s Preventive Services. Agency for Healthcare Research and Quality (AHRQ), June 2022. http://dx.doi.org/10.23970/ahrqepccer256.
Повний текст джерелаMeinhold, C. B. Radiation safety concerns for pregnant or breast feeding patients. The positions of the NCRP and the ICRP. Office of Scientific and Technical Information (OSTI), January 1997. http://dx.doi.org/10.2172/446331.
Повний текст джерелаBrännström, Mats, Ylva Carlsson, and Henrik Hagberg. Obstetric outcome after uterus transplantation. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2023. http://dx.doi.org/10.37766/inplasy2023.1.0052.
Повний текст джерела